34
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents

, , , , , , , & show all
Pages 920-924 | Received 01 Jun 2012, Accepted 29 Aug 2012, Published online: 02 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shoichi Kaneshiro, Kosuke Ebina, Makoto Hirao, Hideki Tsuboi, Masataka Nishikawa, Akihide Nampei, Yoshio Nagayama, Koichiro Takahi, Takaaki Noguchi, Hajime Owaki, Jun Hashimoto & Hideki Yoshikawa. (2017) The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab. Modern Rheumatology 27:1, pages 42-49.
Read now

Articles from other publishers (2)

Takuro Kuboi, Tsuyoshi Tajika, Fumitaka Endo, Wataru Goto, Ichiro Nakajima, Satoshi Hasegawa, Daisuke Nakajima, Takafumi Hosokawa & Hirotaka Chikuda. (2021) Collagenase <i>Clostridium histolyticum</i> Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren’s Disease. Progress in Rehabilitation Medicine 6:0, pages n/a.
Crossref
Nobunori Takahashi, Takayoshi Fujibayashi, Daihei Kida, Yuji Hirano, Takefumi Kato, Daizo Kato, Kiwamu Saito, Atsushi Kaneko, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Hiroyuki Miyake, Tsuyoshi Watanabe, Masatoshi Hayashi, Yasuhide Kanayama, Koji Funahashi, Masahiro Hanabayashi, Shinya Hirabara, Shuji Asai, Toki Takemoto, Kenya Terabe, Nobuyuki Asai, Yutaka Yoshioka, Naoki Ishiguro & Toshihisa Kojima. (2015) Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. Rheumatology International 35:10, pages 1707-1716.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.